---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-21-024792"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2021-07-19T23:59:59+00:00"
generated_at: "2026-06-30T04:39:24.788928+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Brooklyn ImmunoTherapeutics appoints Jay Sial as Chief Administrative Officer effective July 15, 2021

## Summary
- Mr. Sial receives $350,000 base salary and annual bonus eligibility up to 35% of base.
- Equity grant of 71,000 stock options and 35,700 RSUs, each vesting over four years.
- Severance provides 9 months of base salary and COBRA; 12 months if near a change in control.
- Previously CFO at Aspen Neurosciences and University of California Irvine Health.
- Equity awards are inducement grants approved by compensation committee without stockholder vote.

## SEC filing metadata
- accession: 0001140361-21-024792
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2021-07-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000114036121024792/0001140361-21-024792-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000114036121024792/brhc10027031_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-21-024792
- JSON: https://secwatch.observer/filing/0001140361-21-024792.json
- Plain text: https://secwatch.observer/filing/0001140361-21-024792.txt

## Key facts
- Executive change
  Jay Sial was appointed as Chief Administrative Officer at Ernexa Therapeutics Inc..
  - Action: appointed
  - Role: Chief Administrative Officer
  source text: On July 13, 2021, we announced that Jay Sial, had been appointed as our Chief Administrative Officer, effective July 15, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000114036121024792/0001140361-21-024792-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.